Skip to main content

Birmingham/Solihull CCG

Response from Medicines Management

You are perfectly correct that the national intent is of no great surprise and I am sure that you aware that we have advanced plans to release our policy statements on both Flash and Continuous Glucose Monitoring.  We have always aimed to release them in advance of April and they are largely there bar final sign off from our providers, which we do not anticipate to be a major problem.

The guidance issued last week by NHSE has introduced some delay into the process as we now need to update both of our policies to reflect the revised cohort of eligible patients – they are actually a bit different from the original RMOC criteria and are certainly wider.  I am sure you will agree that it would be improper to release guidance based on the RMOC criteria when these have been superseded with what we should probably term NHSE criteria.

As I am sure you are aware, although we have not formally released our guidance, our providers have been working to the documents and have started to make Flash Glucose Monitoring FlashGM available to patients under the RMOC criteria, which I am sure that Dr Narendran will confirm for you.  Up until now, we have classified FlashGM as ‘red’ meaning that the supply is done directly from the provider rather than by GP prescription, and so our national prescribing data will not reflect the true picture.  Going forward, it is highly likely that our initial assessment and initiation of FlashGM will be done in secondary care and prescribing transferred to primary care in four to six weeks after an interim assessment that the intervention is being used as per the guideline.  At this stage, I have no concerns about us meeting the April deadline for making FlashGM available.

To me, this is fascinating as they've seen that Red Listing is probably not the best way.  Up until this point, I'd always assumed BSol would red list.

Comments

Popular posts from this blog

Big Announcement - Libre Funding

NEWS RELEASE Embargoed 00:01 November 14 NHS TO PROVIDE LIFE CHANGING GLUCOSE MONITORS FOR TYPE 1 DIABETES PATIENTS Tens of thousands of people with Type 1 diabetes across the country will benefit from life changing glucose monitors on the NHS. To coincide with World Diabetes Day, Simon Stevens, Chief Executive of NHS England, is announcing action to end the current variation patients in some parts of the country are facing to access Freestyle Libre. The wearable sensor does away with the need for inconvenient and sometimes painful finger prick blood tests by relaying glucose levels to a smart phone or e-reader. NHS England will ensure the device, which is the size of a £2 coin and sits on the arm, is available on prescription for all patients who qualify for it in line with NHS clinical guidelines. From April 2019, these patients will be able to receive it on prescription from their local GP or diabetes team helping them to better manage their blood sugar levels. It comes as the NHS seeks t…

Libre - March 2018 Update

Since November 2017 and the official listing of Libre on prescription, so much has changed, but has it changed for the better?

I think broadly the answer to that question is No, but not for want of trying.  The situation has become increasingly confusing and disjointed.

Getting it on Prescription Firstly, the prescribing of Libre.  Wales have said yes, most other areas have said perhaps.  This map shows the current status by CCG: Diabetes UK Joint Policy Tracker.  There are improvements, but this demonstrates the postcode lottery.

The data on prescribing rates are published but this data is woefully slow to become in the public domain.  The final UK country to publish data was Scotland, which finally released December data on 13th March!

Here's the data so far:

This shows an increase, but hardly an avalanche!  Wish I could see the January data...Northern Ireland should publish very soon though.

There are CCGs like Manchester that have now approved prescribing, but it's slow an…

August Libre Update - Data, data and more data!

This month's update will be dealt with in two parts, both focusing on data; the first part summarising some data about the prescribing policies across England, the second my usual update on prescriptions fulfilled across the UK.
Libre Prescribing Policies and Implementation in England There didn't seem to be an easy way to compile this.  I used the Diabetes UK Map to link to the policies and then I cross-checked this with a Google search to see whether there was any more information.  I had to do this line by line for each of the 195 CCGs in England - quite a lengthy and tedious process.  However, I am pleased with the information arising from the data.

Firstly, the headline figures - how many CCGs were funding Libre, how many had denied funding and who were still undecided?  There are differences of opinion about these figures as some CCGs have not been clear (Staffordshire CCGs), and some have agreed to fund, but are yet to actually fund due to implementation difficulties (L…